Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Spinal Diseases × Melphalan × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 38 Medulloblastoma 9 Lymphoma 9 Sarcoma 8 Brain Neoplasms 8 Central Nervous System Neoplasms 7 Rhabdomyosarcoma 6 Neuroectodermal Tumors, Primitive, Peripheral 6 Wilms Tumor 5 Sarcoma, Ewing 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia 5 Astrocytoma 5 Rhabdoid Tumor 4 Hepatoblastoma 4 Glioma 4 Ganglioneuroblastoma 4 Burkitt Lymphoma 4 Retinoblastoma 3 Ovarian Neoplasms 3 Neuroectodermal Tumors, Primitive 3 Neoplasms, Germ Cell and Embryonal 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

Patient Discharge 1 Melphalan 1 Magnetic Resonance Imaging 1 Infusions, Intra-Arterial 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01637766 2020-08-03

SIAC

Weill Medical College of Cornell University

Phase 1 Completed

Spinal Cord Compression, Spinal Cord Neoplasms, Spinal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡